MDM4 and acute myeloid leukemia: Recent results demonstrate that several AML subgroups can develop TP53 dysfunction due to the occurrence of different events, such as NPM1 and FLT3 mutations, MDM2/MDMX upregulation, fusion proteins promoting chromosomal reciprocal translocations, and aberrant expression of specific miRNAs (132).